Articles

News

Debate Cycle: COVID-19 6-month Pandemic Balance in Brazil

HEALTH SYSTEM, SOCIETY AND VULNERABILITIES

The Fiocruz COVID-19 Observatory organized a cycle of debates to discuss how Brazil responded to the pandemic and ways forward.

All webinars will have English simultaneous translation.

Click on the event title to watch!

Programme:

Sept 9: Epidemiological scenarios of COVID-19 in Brazil: impact evaluation and what´s next
Sept 17: Covid-19 - Challenges for Patient Security
Sept 23: Covid-19 and Social Repercussions: Narratives and evidence on inequalities and vulnerabilities in Brazil
Sept 30: The Covid-19 pandemic: Interfaces between populations, health systems and social inequalities

Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19

Fiocruz produces breast cancer drugs to the Brazilian Health System

Through its Immunobiological Technology Institute in (Bio-Manguinhos/Fiocruz), Fiocruz is now supplying trastuzumab to the Ministry of Health (MoH), which provides it to cancer patients free of cost through the Brazilian Public Health System.

21/08/2020 Bio-Manguinhos/Fiocruz Through its Immunobiological Technology Institute in (Bio-Manguinhos/Fiocruz), the Oswaldo Cruz Foundation is now supplying trastuzumab to the Ministry of Health (MoH), which provides it to cancer patients free of cost through the Brazilian Public Health System (SUSm in ... Read more

Tool foresees long-term pain after chikungunya

Researchers from Fiocruz Bahia researched relevant variables in the acute phase of chikungunya, seeking features that may indicate the patients with greater probability of developing long-term pain in the joints.

30/07/2020 Fiocruz Bahia Chikungunya is a disease caused by a virus, which is transmitted through the bite of the Aedes aegypti mosquito, which may cause symptoms like fever, skin rashes and body pain. According to the Ministry of Health, from ... Read more

Fiocruz is designated as reference institution in Covid-19 in the Americas for the WHO

The Laboratory for Respiratory Viruses and Measles has been formally acknowledged as reference in the continent, together with the CDC

Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more

Return to school is a risk for more than 9.3 million adults in Brazil

The number was calculated through a Fiocruz analysis, along with other partners, based on the National Health Survey (PNS 2013),

27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more

Fiocruz expands actions to confront Covid-19 in indigenous peoples

Researchers from the Oswaldo Cruz Foundation develop a plan to support the fight against Covid-19 among indigenous peoples

03/08/2020 Filipe Leonel (Ensp) e Julia Dias (CCS) Researchers from the Oswaldo Cruz Foundation develop a plan to support the fight against Covid-19 among indigenous peoples. One of the goals is to intensify surveillance and improve information about the impacts ... Read more

Understanding the gendered dimensions of - COVID-19 - #InFocus

Watch the webinar in English 

  

Covid-19: Fiocruz will begin pre-clinical trials for a vaccine

The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2).

12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more

Fiocruz develops a protocol to sequence the new coronavirus

Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2.

02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more

Fiocruz researcher Gustavo Matta says "COVID deaths are not numbers"

WATCH (In portuguese)

  

E-Learning